Business Standard

Thursday, January 09, 2025 | 11:27 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Eris Lifesciences makes quiet debut, ends below IPO price

The stock slipped to Rs 592, 2% below its IPO price of Rs 603, after listing at Rs 612 on the BSE

Eris Lifesciences
Premium

.

SI Reporter Mumbai
Eris Lifesciences slipped 2% to Rs 592, below its initial public offer (IPO) price of Rs 603, after a subdued listing on BSE. The stock listed at Rs 612, 1.5% higher against its issue price on BSE.

The stock ended at Rs 601, after hitting high of Rs 628 post its listing.

On the National Stock Exchange (NSE), the stock was trading at Rs 604, after opening at Rs 611 levels. It touched high of Rs 628 and a low of Rs 593 so far. A combined 3.59 million shares have changed hands on the counter on BSE

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in